A coalition of 20 states is suing six generic drug manufacturers, alleging they illegally conspired to inflate prices of two medications as part of an industrywide price-fixing scheme. The alleged scam, hammered out during dinners, “girls nights out” and parties, “caused a... 
Bristol-Myers Squibb has reached a nearly $20 million settlement with a coalition of U.S. states after accusations the company improperly marketed the blockbuster antipsychotic drug Abilify (aripiprazole). The pharmaceutical giant will pay $19.5 million to 42 states and the... 
By Michelle Llamas 
The Judicial Panel for Multidistrict Litigation issued an order to consolidate dozens of Invokana (canagliflozin) diabetic ketoacidosis (DKA) and kidney damage lawsuits to New Jersey federal court, according to court documents filed Dec. 7. Effective immediately, the Panel...
By Michelle Llamas 
The U.S. Senate has passed legislation intended to speed up Food and Drug Administration drug and device approvals and “cut red tape” at the agency, but critics say it benefits the industry more than patients. The U.S. House of Representatives already approved the bill— known as...
By Michelle Llamas 
Proton pump inhibitors (PPIs) — a class of heartburn drugs that includes Nexium, Prilosec and Prevacid — may increase the risk of stroke, according to research presented at the American Heart Associations’ Scientific Sessions 2016. Dr. Thomas Sehested of the Danish Heart...
By Michelle Llamas 
A Texas jury has ordered pharmaceutical giant Johnson & Johnson to pay over $1 billion to six plaintiffs who said the implant maker hid flaws in its hip implants. A federal jury in Dallas on December 1 concluded that J&J’s DePuy Orthopaedics unit knew about the risk that...
By Michelle Llamas 
The U.S. Food and Drug Administration (FDA) has received reports of acute pancreatitis linked to SGLT2 inhibitor Type 2 diabetes medications, the agency announced on its website. The FDA said it was “evaluating the need for regulatory action” for acute pancreatitis in the SGLT2...
By Michelle Llamas 
UK-based medical device company Smith & Nephew announced a recall of its Modular SMF and Modular Redapt hip implants after it received reports of complaints and adverse events. Smith & Nephew issued an Urgent Field Safety Notice on November 15, 2016 to its customers with...
By Michelle Llamas 
Federal judges have consolidated dozens of lawsuits alleging the blockbuster antipsychotic drug Abilify (aripiprazole) caused compulsive gambling, sex addiction and other disorders. U.S. District Judge M. Casey Rodgers will preside over about 43 compulsive-behavior lawsuits in... Page 3 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.